1612 related articles for article (PubMed ID: 21762767)
1. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
2. Oriental medicine Jangwonhwan reduces Abeta(1-42) level and beta-amyloid deposition in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.
Seo JS; Yun JH; Baek IS; Leem YH; Kang HW; Cho HK; Lyu YS; Son HJ; Han PL
J Ethnopharmacol; 2010 Mar; 128(1):206-12. PubMed ID: 20079417
[TBL] [Abstract][Full Text] [Related]
3. Illite improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer׳s disease through Akt/CREB and GSK-3β phosphorylation in the brain.
Jeon S; Park JE; Lee J; Liu QF; Jeong HJ; Pak SC; Yi S; Kim MH; Kim CW; Park JK; Kim GW; Koo BS
J Ethnopharmacol; 2015 Feb; 160():69-77. PubMed ID: 25457987
[TBL] [Abstract][Full Text] [Related]
4. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.
Hwang SH; Shin EJ; Shin TJ; Lee BH; Choi SH; Kang J; Kim HJ; Kwon SH; Jang CG; Lee JH; Kim HC; Nah SY
J Alzheimers Dis; 2012; 31(1):207-23. PubMed ID: 22543851
[TBL] [Abstract][Full Text] [Related]
5. A modified preparation (LMK03) of the oriental medicine Jangwonhwan reduces Abeta(1-42) level in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.
Seo JS; Jung EY; Kim JH; Lyu YS; Han PL; Kang HW
J Ethnopharmacol; 2010 Aug; 130(3):578-85. PubMed ID: 20669372
[TBL] [Abstract][Full Text] [Related]
6. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
[TBL] [Abstract][Full Text] [Related]
7. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
8. In vitro screening on amyloid precursor protein modulation of plants used in Ayurvedic and traditional Chinese medicine for memory improvement.
Liu LF; Durairajan SS; Lu JH; Koo I; Li M
J Ethnopharmacol; 2012 Jun; 141(2):754-60. PubMed ID: 21920424
[TBL] [Abstract][Full Text] [Related]
9. SuHeXiang Wan essential oil alleviates amyloid beta induced memory impairment through inhibition of tau protein phosphorylation in mice.
Jeon S; Hur J; Jeong HJ; Koo BS; Pak SC
Am J Chin Med; 2011; 39(5):917-32. PubMed ID: 21905282
[TBL] [Abstract][Full Text] [Related]
10. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.
Toledo EM; Inestrosa NC
Mol Psychiatry; 2010 Mar; 15(3):272-85, 228. PubMed ID: 19621015
[TBL] [Abstract][Full Text] [Related]
11. Improving memory and decreasing cognitive impairment in Tg-APPswe/PSEN1dE9 mice with Aβ3-10 repeat fragment plasmid by reducing Aβ deposition and inflammatory response.
Ma Y; Li Y; Zong LX; Xing XN; Zhang WG; Cao YP
Brain Res; 2011 Jul; 1400():112-24. PubMed ID: 21658683
[TBL] [Abstract][Full Text] [Related]
12. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
[TBL] [Abstract][Full Text] [Related]
13. Clozapine Improves Memory Impairment and Reduces Aβ Level in the Tg-APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.
Choi Y; Jeong HJ; Liu QF; Oh ST; Koo BS; Kim Y; Chung IW; Kim YS; Jeon S
Mol Neurobiol; 2017 Jan; 54(1):450-460. PubMed ID: 26742522
[TBL] [Abstract][Full Text] [Related]
14. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
[TBL] [Abstract][Full Text] [Related]
18. Behavioral stress causes mitochondrial dysfunction via ABAD up-regulation and aggravates plaque pathology in the brain of a mouse model of Alzheimer disease.
Seo JS; Lee KW; Kim TK; Baek IS; Im JY; Han PL
Free Radic Biol Med; 2011 Jun; 50(11):1526-35. PubMed ID: 21382475
[TBL] [Abstract][Full Text] [Related]
19. A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model.
Wei L; Yang H; Xie Z; Yang S; Yang H; Zhao C; Wang P; Xu S; Miao J; Zhao B; Bi J
J Alzheimers Dis; 2012; 30(3):531-43. PubMed ID: 22451314
[TBL] [Abstract][Full Text] [Related]
20. Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit?
Dragicevic N; Bradshaw PC; Mamcarz M; Lin X; Wang L; Cao C; Arendash GW
Neuroscience; 2011 Jun; 185():135-49. PubMed ID: 21514369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]